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Introduction 17
Every year, approximately 15 million infants are born before 37 completed weeks of gestation and of 18 those, 1.1 million die from complications resulting from their premature birth. In 2018, the incidence of 19 prematurity in the United States was 10.4% [1] and worldwide incidences reached approaching 20% in some 20 regions [2] . There are two primary clinical classifications: spontaneous preterm birth (sPTB) and iatrogenic 21 preterm birth as a result of fetal or maternal complications. Advances in the study of sPTB have allowed the 22 distinction of births due to infection or truly idiopathic spontaneous preterm birth (isPTB). Yet, these broad 23 classifications do not adequately describe the heterogeneous nature of preterm birth nor have they allowed for 24 a systematic understanding of the underlying molecular mechanisms driving the observed heterogeneity. This 25 has led to a lack of diagnostics and effective therapeutic interventions in the clinical setting. 26 the underlying molecular mechanisms of sPTB remain unclear [3] . Furthermore, the molecular differences 28 between infection and isPTB are not well understood. However, one key to understanding the heterogeneity 29 associated with preterm birth may be the placenta, a transient two-sided organ, contributing to the 30 maternal/fetal interface, and along with its proper development and function is essential to a successful 31 pregnancy outcome [4] . Placentation is the result of a highly complex web of molecular interactions 32 originating from both the mother and the fetus. We do not fully understand these processes in healthy, term 33 pregnancies let alone their impact on adverse pregnancy outcomes [4] [5] [6] . However, recent studies utilizing 34 placental pathology have started to provide insights into the morphological differences in preterm birth. 35 Morgan et al., conducted histological studies of the villous trophoblast in isPTB and infection (<37 36 weeks GA) and identified four distinct morphological subclasses between isPTB and infection. Within the 37 isPTB samples, one subclass, comprising 59% of the samples, had morphological hallmarks indicative of term 38 placenta and was classified as having advanced villous maturation (AVM) [7] . The second subclass had none 39 of these hallmarks and made up the remaining 41% of the samples examined [7] [8] [9] . These data suggested over 40 half of isPTB samples were associated with hypermature placentas. These authors also examined a set of 41 infection samples and observed that in contrast to the isPTB, 19% had hallmarks of AVM in addition to 42 infection while the remaining 81% had only infection. A second study by Nijman et al., also examined 43 placental villous histology in spontaneous preterm births between 24 weeks and 36.6 weeks gestation using 44 morphological hallmarks associated with maternal villous malperfusion (MVM) of which AVM is a specific 45 subtype [7, 10] . Again, spontaneous preterm samples were associated with four different morphologies: only 46 hallmarks of MVM, only hallmarks of infection, hallmarks of both MVM and infection, and with some 47 samples having no distinct morphological hallmarks at all, thus confirming the findings of the Morgan et al 48 study. Interestingly, these morphologies tracked with gestational age; with samples between 24-28 weeks 49 having predominately infection hallmarks alone or MVM and infection hallmarks, while those samples 50 between 28-36.6 weeks had predominately either MVM hallmarks or none at all [10] . Together, these two 51 studies suggest at least four subclasses of sPTB exist based on histological observations of the placental villous 52 tissue and these subclasses are likely contributing to the heterogeneity confounding identification the 53 underlying etiology of isPTB. 54
We know from molecular studies of normal term pregnancies, there is coordinated development and 55 maturation between the fetus and the placenta throughout gestation with placental villous remodeling 56 occurring between 20-40 weeks [5] . This remodeling leads to the increase in terminal villi density which 57 reflects an enlarged placental surface area, allowing for increasing nutrient transport to accommodate the 58 growing fetus. Given the morphological evidence for hypermaturity of the placental villous tissue, we 59 hypothesize there is a developmental disconnect occurring in a subset of isPTB pregnancies where the 60 molecular mechanisms associated with normal maturation are aberrant resulting in the hypermaturity 61 observed in the Morgan and Nijman studies, resulting in the premature initiation of parturition resulting in 62 preterm birth. We further hypothesize placentas with infection lesions lack this developmental disconnect as 63 the infection is likely inducing activation of inflammatory pathways associated with parturition initiation, 64 resulting in early delivery. To test these hypotheses and to identify placental molecular mechanisms of preterm 65 subtypes, we obtained histologically phenotyped placental villous samples from isPTB and acute histologic 66 chorioamnionitis(AHC) births between 29 and 36 weeks and normal term births between 38 and 42 weeks, 67 generated transcriptomes and through comparative computational analyses, identified distinct molecular 68 signatures for isPTB and AHC births. 69
Results 70

Study Cohort 71
Maternal and fetal characteristics for the three different pregnancy outcomes included in the 72 transcriptomic analyses are presented in Table 1 . Significant differences were observed in gestational age and 73 fetal weights between AHC and isPTB samples compared to the term samples (P<0.05). Among the isPTB 74 samples, two neonates were small for gestational age (SGA) with a fetal weight less than the 10 th percentile 75 with the remaining neonates above the 50 th percentile for birth weight. All AHC and term births for which 76 there were fetal weights available were appropriate for gestational age. We included males and females in 77 each sample set and adjusted the linear models for fetal sex in addition to birth outcome. It is important to 78 note that in this study, we have mixed ethnic background within each of the sample sets. 79
Identification of significant differentially expressed genes 80
Due to the origin of the samples and inclusion of a pre-existing dataset, we performed multiple 81 assessments to identify potential batch effects which would confound downstream analyses and determined 82 there were no significant batch effects identified. Thus, we did not remove or control for them in subsequent 83 models or tests for differential gene expression. The data matrix was filtered and normalized within edgeR 84 (Emperical Analyses of Digital Gene Expression in R) [11] , leaving us with a total of 13,929 genes in the data 85 matrix for analysis. 86
To account for the type of birth and fetal sex differences, we utilized the generalized linear modeling 87 function (glm) within edgeR. Once the model was built, we conducted differential gene expression testing 88 using three pairwise comparisons: isPTB compared to term births (TB), AHC compared to isPTB, and AHC 89 compared to TB. Genes were considered significant with an adjusted P-value of <0.05 and absolute log2 fold-90 change >1.0 ( Figure 1A ). In the isPTB vs TB comparison, we identified a total of 188 significant differentially 91 expressed genes, with 183 upregulated and only 5 downregulated. The AHC vs isPTB comparison, 92
representing the samples of the same gestational age, yielded a total of 347 significant differentially expressed 93 genes, with 96 upregulated and 251 downregulated. In the final comparison, AHC vs TB, we identified 187 94 significant differentially expressed genes with 137 upregulated and only 50 downregulated ( Figure 1A ). To 95 identify transcriptomic signatures due to isPTB or AHC pathophysiology, we needed to categorize potential 96 candidate genes as those with an isPTB or AHC expression pattern. We intersected the genes, both upregulated 97 and downregulated, from each of the differential gene expression comparisons ( Figure 1B ). We were able to 98 parse the genes into AHC and isPTB categories as well as some that did not fit either category but appeared 99 to be gestationally age related. 100
The transcriptomic signature of isPTB is distinct from AHC and normal term samples 101
We furthered refined our analyses by assessing the expression pattern of each candidate genes in each 102 group across all three differential expression datasets (Figure 2A and B). To be categorized as an isPTB 103 candidate, a gene needed to be upregulated/downregulated in the isPTB compared to AHC or TB, and ideally 104 demonstrating a non-significant difference in the AHC vs TB comparison (Log2 fold-change <1). We 105 identified total of 170 genes that generally fit this expression pattern, all upregulated in their respective isPTB 106 comparisons (Supplemental Table S2 ). 102 of these genes had an expression pattern where the fold-changes 107 were greater in the isPTB vs TB comparison than in the isPTB vs AHC comparison. Not all genes AHC vs 108 TB comparison fit our criteria for a non-significant or no difference. Several genes do have a significant 109 difference in that comparison although it was to a lesser extent compared to the isPTB comparisons, indicating 110 an underlying basal expression level in these genes during gestation. Upregulation in the AHC vs TB 111 comparison indicates high expression earlier in gestation that declines with advancing gestational age ( Figure  112 2A). The remaining 68 genes had a slightly different expression pattern, where the fold-change in expression 113 between isPTB and AHC was greater than fold-change in expression between isPTB and TB and with 114 essentially no significant difference in the TB vs AHC comparison, suggesting these genes belong to a specific 115 isPTB molecular signature ( Figure 2B ). Given the isPTB and AHC comparison represents a comparison 116 between overlapping gestational ages, this expression pattern suggests a hypermaturity molecular signature. 117
We also observed that in this group of genes, that upregulation in the TB vs AHC comparison suggestion 118 expression earlier in gestation that increases with advancing gestational age ( Figure 2B ). 119
IGFBP1 and DKK1 are upregulated in syncytiotrophoblasts in isPTB 120
We validated upregulation of two isPTB candidate genes, IGFBP1 and DKK1 using 121 immunohistochemistry (IHC) on TB and isPTB placental samples. Both proteins localize to the 122 syncytiotrophoblast in TB samples with a marked increase in expression in the isPTB samples ( Figure 3 ). The 123 reduced expression in the term tissues confirms the observations made in the isPTB expression data that there 124 is basal expression of these genes during gestation. 125
The AHC transcriptomic signature does not overlap with the isPTB signature 126
We conducted a similar categorization of AHC genes (Figure 4 ) where the expression in the AHC 127 comparisons were upregulated or downregulated compared to isPTB and TB which were expected to show a 128 no difference in expression. We identified 170 genes that do not overlap with the isPTB candidates, 129 representing a distinct AHC transcriptomic signature (Supplemental Table S3 ). The AHC signature includes 130 137 upregulated genes and unlike the isPTB signature, 33 downregulated genes ( Figure 3 ). Within the isPTB 131 vs TB comparison, there are no genes that are differentially expressed, indicating a similar expression pattern 132 within these respective birth types. 133 isPTB candidate genes represent upregulated growth and inflammation pathways 134
We were able to identify molecular pathways of interest by analyzing our isPTB candidate genes lists 135 through statistical overrepresentation. Our analysis of the isPTB candidate genes returned four significant 136 pathways ( Table 2) . Of these pathways, two are directly associated with specific signaling pathways: the 137 regulation of IGF uptake and transport by IGFBPs and cytokine signaling with the remaining pathways being 138 more generalized to the immune system and signal transduction. 139
AHC candidate genes indicate increased mitotic activity 140
We conducted pathway analysis of the AHC candidate genes using statistical over-representation and 141 identified 22 significant pathways (Table 3 ). 20 pathways are associated with regulation of cell cycling and 142 mitosis ( Table 3) . Many of the genes overlap with multiple pathways. The remaining two pathways are 143 associated with general cellular senescence and more specifically, DNA damage/telomere stress induced 144 senescence. 145
Discussion: 146
Understanding the etiology of each of the subtypes of preterm birth previously identified by studies in 147 placental histopathology [8] [9] [10] will allow for better clinical diagnosis and treatment. We conducted three 148 pairwise comparisons between placentas from preterm births within a linear model accounting for fetal sex 149 and gestational age, then isolated common and unique signatures to isPTB and AHC. We further refined the 150 unique signatures into specific lists of significant candidate genes then examined the lists to identify potential 151 molecular pathways of interest to the pathophysiology of isPTB. 152
Within the unique isPTB signature, we observed significant over-representation of genes in insulin 153 like growth factor signaling pathway: IGFBP1, IGFBP2, IGFBP6, C3, MELTF, CP, TNC, and CHDRL1. The 154 upregulation of the IGFBPs could have multiple paracrine and autocrine implications throughout the context 155 preferentially binds IGF2, reducing their bioavailability to activate IGF signaling [14] . The aberrant increase 157 in IGFBP1, IGFBP2, and IGFBP6 in isPTB placentas may suggest a reduction in IGF signaling, however we 158 do not see reduced fetal weight in the majority of our samples suggesting placental supply to maintain fetal 159 growth via the mTOR pathway is not affected [15, 16] . 160 IGFBP2 and IGFBP6 have roles independent of IGF signaling. IGFBP2 has been associated with 161 enhanced cell proliferation via extracellular interaction with EGFR and the activation of the STAT3 signaling 162 pathways [17] . It can also translocate to the nucleus to act as a transcription factor promoting VEGF expression 163 [20, 21] . Interestingly, IGFBP2 has a non-canonical promoter comprised of four putative NFKB binding sites. 164 NFKB has previously been implicated in the activation of pro-labor pathways through non-canonical signaling 165 via activation of the STAT3 pathways [18] . It is possible that increased IGFBP2 is activating EFGR/STAT3 166 due to NFKB or other signaling resulting in increased placental maturation and the premature activation of 167 pro-labor pathways and thus, isPTB. 168
Independent of its roles in IGF signaling, IGFBP6 can inactivate WNT signaling by blocking WNT 169 binding to the FDZ and LRP receptors [19] . WNT signaling is essential to placental development through STB 170 differentiation, and most likely, the suppression of NFKB signaling, limiting the initiation of pro-labor 171 inflammatory pathways [20] . Increased IGFBP6 would abrogate WNT signaling and the associated biological 172 processes. While the WNT/B-catenin and NFKB cross-talk has not been fully explored in villous tissue, the 173 upregulation of non-canonical NFKB pathways has been associated with the activation of pro-labor 174 inflammatory pathways in villous trophoblasts of normal placentas [18] . Thus, the upregulation of IGFBP6 175 could represent premature activation of pro-labor pathways. IGFBP6 also functions at the intercellular level 176 through its binding of Ku-80. Ku-80 functions in non-homologous DNA repair and the interaction with 177 IGFBP6 is associated with cell cycling [21] . Furthermore, Ku proteins including Ku-80 have been implicated 178 in telomere maintenance including maintaining telomere length which is associated biological aging [21] . 179
Once a critical shorten length is reached, senescence is activated along with a corresponding hyperactivity of 180 NFKB, TNFa, IL6, and IFNg all known to have roles in activation of pro-labor pathways [21, 22] It has been 181 the evidence thus far has been conflicting [23] [24] [25] perhaps due to the lack of appropriate placental 183 phenotyping. Elucidating the non-canonical roles of IGFBP2 and IGFBP6 in villous tissues could provide 184 additional insights to the molecular mechanisms underpinning isPTB. 185
Our immunohistochemistry studies support the transcriptome data demonstrating both increased 186 IGFBP1 and DKK-1 protein expression. DKK1 is a WNT signaling inhibitor and WNT signaling is essential 187 to the development and maturation of the placenta potentially through the differentiation of trophoblasts [26] . 188
Just as IGFBP6 could be modulating the WNT-NFKB crosstalk and signaling, so to could DKK1 as they both 189 function to block WNT singling by binding to the receptor [27] and thus activate pro-labor inflammatory 190 pathways. 191 TNC, C3, CP, MELTF, and CHRDL1 upregulation maybe due to the activation of RAS signaling 192 through either the IGF signaling pathway [12] , or possibly through IGFBP2 activation of EGFR or cytokine 193 activation of growth factor signaling. TNC, C3, CP represent inflammatory markers [28] [29] [30] [31] , while CHRDL1 194 is a marker of cellular aging and BMP4 agonist, likely signaling the arrest of BMP4 related cell proliferation 195 [32, 33] . TNC and C3 are of particular interest due to their roles in physiological processes central to placental 196 maturation. Furthermore, they have been extensively studied in the context of cancer progression and 197 inflammatory processes, with diagnostics and potential therapeutics already in place or in 198 development [28, 34] . TNC modulates numerous biological processes such inflammation, branching 199 morphogenesis, epithelial-mesenchymal transformations, mediation of cell signaling through interactions 200 connecting ECM molecules to cell membrane receptors such as TRL4, FRZ, EGFR, and integrins [28] . The 201 upregulation of TNC in our isPTB samples could be indicative of increased branching of the villi coupled 202 with increased cell signaling through its interaction with cell membrane receptors. As we are only examining 203 the endpoint of gestation, we are unable to determine if TNC expression is upregulated throughout gestation, 204 leading to premature branching and thus, hypermaturation. Given the lack of study in the placenta, TNC is a 205 novel candidate for further study in placental isPTB pathophysiology. 206
In addition to the upregulation of C3, identified by its association with the over-represented IGF 207 signaling pathway, we observed upregulation of other complement related genes, C1R and CFH. The 208 complement system has a key role in pregnancy, especially during the development of the maternal-fetal 209 interface where the establishment of maternal immunotolerance allows for a semi-allogeneic existence 210 between fetus and mother yet also protect the mother and fetus from infection [34] . Previous studies 211 demonstrated elevated levels of C3a, a cleavage product of C3, at 20 wks gestation was associated with 212 various adverse pregnancy outcomes classified as iatrogenic preterm or sPTB compared to normal term births, 213 however the authors did not distinguish the different subclassification of preterm birth such as preeclampisa 214 (PE), interuterine growth restriction (IUGR), or isPTB [35] . While the upregulation of C3 in our data could be 215 extrinsic to IGF pathway activation, the co-expression and upregulation of C1R, a complement initiator, 216 suggests the activation of the classical pathway [34, 35] . However, the corresponding upregulation of CFH, a 217 complement regulator, suggests that an alternative pathway could also be activated, which in the absence of 218 infection could indicate damaged tissue [34, 35] . While there is a growing body of evidence, including our 219 data, that associates the complement system with PTB, and especially isPTB, it is unclear if it is a consequence 220 or contributor to the pathology. 221
In stark contrast to the isPTB signature, the AHC signature we observed was associated with mitotic 222 and cell cycling pathways suggesting active cell division in these placentas. This would be expected at this 223 gestational age range as the placenta is actively remodeling and expanding to accommodate exponential fetal 224 growth [4] . While our AHC candidate gene list from villous tissue does differ from that of Ackerman et al [40] , 225 both analyses identified a set of histones upregulated from the HIST1 locus on Chr6p21-22, suggesting there 226 is active replication occurring in the AHC samples. Furthermore, their pathway analyses included numerous 227 pathways associated with active growth including telomere maintenance, deposition of CENPA and various 228 RNA Pol I related pathways even though their samples are of a much younger gestational age [40] . Together 229 these data do suggest that AHC placentas are in an active growth phase appropriate for their gestational age 230 and that although they are preterm due to infection, they are well suited to be controls for future studies. In 231 contrast, in the isPTB placentas of the same gestational age range as the AHC placentas we did not detect this 232 growth signature, instead there was a lack of significant difference in gene expression between isPTB and TB, 233 suggesting that these placentas are more similar in growth pattern to the term placenta, further supporting 234 advanced placental maturation. Interestingly, the most upregulated gene in the AHC samples, CDKN1C 235 (cyclin dependent kinase inhibitor 1C), is located on Chr11p15.5, an essential placental imprinted locus with 236 roles in placental and fetal growth(ref). 237
The expression pattern observed in our AHC data suggests the imprinting is appropriate in the AHC samples 238 allowing for the transcription of CDKN1C from the maternal allele [36] . In contrast to the AHC expression 239 pattern, the PTB and TB patterns are very similar for each gene. Aberrant expression of Cdkn1c in mice has 240 been associated with increased fetal and placental growth coupled with changes in placental morphology [37] . 241
Other genes in the locus such as Phlda2 have been associated with placental overgrowth but without the 242 associated fetal overgrowth in mice [38] . We were not able to assess PHLDA2 expression as it was not well 243 expressed in our data set and subsequently filtered out of the final data set used for analysis. While there is 244 synteny between the mouse and human loci, the mechanisms of regulation via imprinting are different [37, 39] . 245 However, given the potential implication on placental specific growth and morphology, it should be 246 considered for further study. 247
One caveat of the current study, as with other studies, is the lack of normal placentas at early 248 gestational ages which made it necessary to identify appropriate controls. In most studies, gestational aged-249 matched placentas have an underlying iatrogenic pathology such as PE. Both the Nijman and Morgan studies 250 indicated that the iatrogenic samples commonly used as controls also have MVM and would likely confound 251 the molecular signatures we sought to identify [8, 10] . The AHC samples we chose were designated infected 252 by histological examination, but the villi did not appear to be damaged or inflamed, making it an ideal 253 gestational age control for our study. A second caveat is how we identified the infected specimens. The 254
Ackerman et al study confirmed infection through testing of the amniotic fluid. However, our infected 255 specimens were identified by histological analyses. This could explain the differences in our infection related 256 gene lists. 257 gestationally age-matched AHC samples. These signatures highlight the necessity to carefully phenotype 259 sPTB into the respective AHC and isPTB subclasses to pinpoint the potential molecular mechanisms 260 underlying the pathophysiology of isPTB. Ultimately, the insights gained from understanding the differences 261 between AHC and isPTB will improve our ability to differentiate and predict isPTB quite possibly through 262 non-invasive methods. More, importantly, understanding the molecular etiology of isPTB associated with 263 placental hypermaturity may provide translational approaches beyond diagnostics such as treatment of the 264 placenta to ensure appropriate development and birth timing. 265 sequencing power calculation from [40] ( Supplemental Table S1 ), it was determined that between 5-9 276 transcriptomes for this particular study to get a powered analysis between 70-90% power at a 2-fold change 277 in expression. We opted for higher power and thus, previously published placental villous transcriptomes 278 generated through RNA sequencing were also utilized (GEO GSE73714 term=5, isPTB=4, inter-amniotic 279 infection=1) [41] bringing our final sample totals to the following: term=11, isPTB=12, and infected=9 (Table  280 1). Birth weight percentiles were estimated using the WHO weight percentiles calculator with an US average 281 birth weight of 3400gm [42] . It is important to note that the AHC samples were received several months after 282 the study was initiated. Therefore, their transcriptome data were generated after the rest of the data resulting 283 in two batches of data and potential for a batch effect. We have described our assessment and corrections of 284 the batch effects in the respective methods below. 285
Materials and Methods 266
Clinical definitions 286
Gestational age was established based on last menstrual period confirmed by an ultrasonographic examination 287 prior to 20 weeks [43] . 
Transcriptome Generation 296
All placental samples from GAPPS, RCWIH, and UCMC which were collected within 60 minutes of delivery 297 and snap frozen prior to biobanking. Total RNA was prepared from placental villous samples thawed in 298
RNAIce Later (Invitrogen) as per manufacturer instructions. Total RNA was isolated using the RNAeasy Mini 299 Kit (Qiagen). 50-100 µg of total RNA was submitted to the University of Cincinnati Genomics, Epigenomics 300 and Sequencing Core for RNA quality assessment and sequencing. RNA total libraries were generated using 301 a RiboZero Kit (Illumina) and sequencing was run on an Illumina High Seq 2000 system to generate single 302 end 50bp reads at a depth of 50 million reads. Details on the collection of placental samples and generation 303 of transcriptomes from GSE73714 can be found here [41] . 304
RNA-sequence data preparation 305
To facilitate RNA sequence analyses, a local instance of the Galaxy [46] was utilized with the following tools: 306 FASTQC (Galaxy v0.71) [47] , TrimGalore! (Galaxy v0.4.3.1) [48] , Bowtie2 (Galaxy v2.3.4.1) [49] , and 307
FeatureCounts (Galaxy v1.6.0.3) [50] . The quality of the raw fastq files was assessed with FASTQC and with 308 adapters subsequently trimmed with TrimGalore. Trimmed sequences were then aligned to the University of 309 genes expressed in the placental tissues, we set the Bowtie2 parameters as sensitive end to end. FeatureCounts 311 was used to generate total read counts per gene and to generate a count matrix file to be used in differential 312 gene expression analyses. 313
Differential Expression Analyses 314
After annotation, all non-coding transcripts were removed from the count matrix. Using edgeR (Emperical 315
Analyses of Digital Gene Expression in R), the count data was then filtered using the counts per million 316 (CPM) method to allow for various quality control analyses to ensure the data was ready for differential 317 expression testing [11] . All data were normalized as a single data set using TMM (trimmed means of m values) 318
to account for differences in library sizes [51] . After normalization, we assessed the data matrix for potential 319 batch effects using principle components analyses (PCA) and did not observe significant batch effects; 320 therefore, no correction was applied to preserve meaningful biological variation. A generalized linear model 321 (glm) was built (using limma within the edgeR framework) to assess differential gene expression across all 322 birth types accounting for fetal sex. As the entire cohort was small, we did not assess additional covariates for 323 this study. Once the model was generated, we examined the differential expression testing using pairwise 324 contrasts within the model. Multiple corrections testing was performed using the Benjamini Hochberg method 325 with a Q value of <0.05. 326
Transcriptomic signature identification 327 Venny v2.0 was utilized to generate Venn diagrams and identify candidate genes for isPTB and AHC 328 signatures. Candidate genes along with their expression patterns were loaded into Excel and sorted by fold 329 change. The isPTB signature was defined as genes having an upregulated or downregulated expression pattern 330 when compared to AHC or TB and with the AHC vs TB comparison having a non-significant fold change. 331
The AHC signature was defined as genes having upregulated or downregulated expression pattern when 332 compared to isPTB or TB and with the isPTB vs TB comparison having a non-significant fold change. 333
Heatmaps were generated in Prism v8 (GraphPad). 334 335 Immunohistochemistry was performed as previously published [52] . Briefly, all slides were incubated 95°C 337 target retrieval solution for 30 minutes then washed in deionized water. Slides were then incubated in 3% 338 hydrogen peroxide for 10 minutes followed by blocking in 10% normal goat serum +1% bovine albumin for 339 60 minutes. Primary antibodies generated in rabbit sera were diluted in phosphate buffered saline (PBS): 340 DKK1 (1:20, GeneTex GTX40056) and IGFBP1 (1:50, GeneTex GTX31149). Slides were incubated 341 overnight at 4°C washed and incubated with biotinylated secondary antibody (anti-rabbit) for 60 minutes. 342
Antibody binding was detected using DAB and slides were counterstained with hematoxylin. All slides were 343 imaged on a Nikon Eclipse 80i microscope. 344
Signaling Pathway Analyses 345
Significant genes divided into molecular signature categories were entered into the Panther Pathway DB [53] Pathological isPTB candidate genes were identified by assessing the differential expression across all three pairwise comparisons. isPTB candidate genes had significant upregulated expression in isPTB samples compared to TB and AHC, with the either no change in expression pattern between AHC and TB or upregulation in AHC, although to a lesser extent than observed in the isPTB samples. This slight upregulation in AHC samples indicates a baseline expression is higher in samples of earlier gestational age and decreases over term. B. isPTB hypermaturity genes were also identified in the same manner as those in Panel A with the reversal of expression assessment between AHC and TB. In this analysis, we observed that the expression of these genes increases over gestation with expression being increased in TB samples compared to AHC. More importantly, when comparing isPTB to AHC which overlap in gestational age, there is a significant upregulation in isPTB samples which is suggestive of hypermaturity. Genes are arranged in order of Log2 fold change in the isPTB vs AHC comparison. Values = Log2 fold change 
